Changes in Lung Function during Platinum-based Chemotherapy for Patients with Lung Cancer

被引：0
|
作者：
Goetschke, J. [1 ,2 ]
von Wachter, C. [3 ]
Sellmer, L. [1 ,2 ]
Mertsch, P. [4 ]
Kauffmann-Guerrero, D. [5 ,6 ]
Syunyaeva, Z. [7 ,8 ]
Alpay, N. [3 ]
Tufman, A. [9 ,10 ]
机构：
[1] Klinikum Ludwig Maximilians Univ Munchen, Comprehens Pneumol Ctr Cpc M, Med Klin 5, Munich, Germany
[2] Deutsch Zentrums Lungenforsch, Giessen, Germany
[3] Klinikum Ludwig Maximilians Univ Munchen, Med Klin 5, Munich, Germany
[4] Klinikum Univ Munchen, Med Klin & Poliklin 5, Mukoviszidose Zentrum Erwachsene, Munich, Germany
[5] Univ Munich Lmu, Dept Internal Med 5, Comprehens Pneumol Ctr, Munich, Germany
[6] German Ctr Lung Res Dzl, Munich, Germany
[7] Klinikum Univ Munchen, Med Klin & Poliklin 5, Sekt Pneumol & Thorakale Onkol, Munich, Germany
[8] Lungentumorzentrum Munchen, Munich, Germany
[9] Ludwig Maximilian Univ Munich, Dept Internal Med 5, Div Resp Med & Thorac Oncol, Munich, Germany
[10] Thorac Oncol Ctr, Munich, Germany
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
10.1055/s-0039-3403179
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P215
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [1] Thromboembolic events in lung cancer patients treated with platinum-based chemotherapy
    Rouis, Houda
    Kamoun, Hela
    Rejeb, Hadhemi
    Ben Tkhayat, Achraf
    Smadhi, Hanen
    Greb, Dorra
    Ben Abdelghaffar, Hajer
    Akrout, Ines
    Hassene, Hela
    Fekih, Leila
    Megdiche, Mohamed Lamine
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] Markers of response to platinum-based chemotherapy in lung cancer
    Barr, Martin P.
    MacDonagh, Lauren
    O'Byrne, Kenneth J.
    [J]. LUNG CANCER MANAGEMENT, 2013, 2 (03) : 227 - 239
  • [3] Predicting toxicity in advanced lung cancer patients treated with platinum-based chemotherapy
    Ioannidis, Georgios
    Souglakos, John
    Georgoulias, Vassilis
    [J]. LUNG CANCER MANAGEMENT, 2013, 2 (04) : 281 - 293
  • [4] Weight Loss Associated with Platinum-Based Chemotherapy in Patients with Advanced Lung Cancer
    Morio, Kayoko
    Minami, Toshiyuki
    Sozu, Takashi
    Niki, Kazuyuki
    Kijima, Takashi
    Uejima, Etsuko
    [J]. CHEMOTHERAPY, 2015, 61 (05) : 256 - 261
  • [5] Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy
    Liu, Jia-Si
    Liu, Jun-Yan
    Xiao, Qi
    Li, Xiang-Ping
    Chen, Juan
    Liu, Zhao-Qian
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Resistance to platinum-based chemotherapy in lung cancer cell lines
    Jianli Chen
    Nashwa Emara
    Charalambos Solomides
    Hemant Parekh
    Henry Simpkins
    [J]. Cancer Chemotherapy and Pharmacology, 2010, 66 : 1103 - 1111
  • [7] Resistance to platinum-based chemotherapy in lung cancer cell lines
    Chen, Jianli
    Emara, Nashwa
    Solomides, Charalambos
    Parekh, Hemant
    Simpkins, Henry
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (06) : 1103 - 1111
  • [8] Perioperative Nivolumab in combination with platinum-based Chemotherapy for Patients with Stage III Lung Cancer
    Hekmat, Khosro
    Bruns, Christiane J.
    [J]. CHIRURGIE, 2024, 95 (02): : 161 - 162
  • [9] COMPARISON OF GEFITINIB AND PLATINUM-BASED CHEMOTHERAPY AND ONLY PLATINUM-BASED CHEMOTHERAPY TO TREAT LUNG ADENOCARCINOMA
    Yang, L.
    Fan, J. H.
    Liu, L. L.
    Su, Y.
    Lu, D.
    Huang, J. Y.
    Zhang, H.
    Li, Y.
    Huo, H. D.
    Du, Z. H.
    Liu, G. T.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2018, 32 (03): : 613 - 618
  • [10] Circulating Survivin Protein Levels in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
    Puskas, Rita
    Bikov, Andras
    Horvath, Peter
    Lazar, Zsofia
    Kunos, Laszlo
    Nagy, Reka
    Pinter, Gabriella
    Galffy, Gabriella
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
12345